Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Blue Earth Therapeutics Ltd
Blue Earth Therapeutics Ltd
Celcuity Inc
Pathos AI, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Cedars-Sinai Medical Center
K36 Therapeutics, Inc.
Antev Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Institut Curie
University of Miami
AdventHealth
Imperial College London
Advanced Accelerator Applications
Jonsson Comprehensive Cancer Center
Endocyte
Marmara University
Poseida Therapeutics, Inc.
UNICANCER
Fundacion Oncosur
VA Greater Los Angeles Healthcare System
The First Affiliated Hospital with Nanjing Medical University
Intuitive Surgical
Steba Biotech S.A.
Northwell Health
Northwell Health
Beth Israel Deaconess Medical Center
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Aragon Pharmaceuticals, Inc.
Novo Nordisk A/S
Region Skane
Menoufia University
Oslo University Hospital
Hisar Intercontinental Hospital
OHSU Knight Cancer Institute
Institut Bergonié
British Columbia Cancer Agency
University Health Network, Toronto
Advanced Accelerator Applications
Steba Biotech S.A.
Azienda Ospedaliero-Universitaria di Modena
University of Aarhus
NanOlogy, LLC
Icahn School of Medicine at Mount Sinai
Steba Biotech S.A.
Rigshospitalet, Denmark
Cedars-Sinai Medical Center
ESSA Pharmaceuticals
Novartis
Dendreon
Helse Stavanger HF